Clinical Trial Update: Profitability Trial in Primary Preventive Implantable Cardioverter-defibrillator Recipients

View source ↗

Summary

The profitability trial in primary preventive implantable cardioverter-defibrillator recipients has been terminated. The sponsor is University Hospital Ostrava.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy
• Nonischemic Cardiomyopathy

Snippet

Sponsor: University Hospital Ostrava | Conditions: Ischaemic Cardiomyopathy, Non-ischaemic Cardiomyopathy | Status: TERMINATED